{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":20,"n_cols":5,"rows_kept":20,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[9,2,9,3],[10,2,10,3],[14,2,14,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910779515903321"]
[null,null,"Titolo",null,"Thyroid hormones [[electronic resource] ] : functions, related diseases and uses / / Francis S. Kuehn and Mauris P. Lozada, editors"]
[null,null,"Pubbl/distr/stampa",null,"New York, : Nova Biomedical Books, c2009"]
[null,null,"ISBN",null,"1-60876-647-0"]
[null,null,"Descrizione fisica",null,"1 online resource (236 p.)"]
[null,null,"Collana",null,"Endocrinology research and clinical developments series"]
[null,null,"Disciplina",null,"612.4/4"]
[null,null,"Soggetti",null,"Thyroid hormones"]
[{"$nulls":4},"Hormones"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"\"\"Thyroid Hormones: Functions, Related Diseases and Uses\"\"; \"\"Contents\"\"; \"\"Preface\"\"; \"\"Thyroid Hormone Transport across Blood-Brain Barriers\"\"; \"\"Abstract\"\"; \"\"Abbreviations \"\"; \"\"1. Thyroid Hormone \"\"; \"\"2. Blood-Brain Barriers \"\"; \"\"3. Thyroxine Transporters \"\"; \"\"4. TH Efflux System \"\"; \"\"5. The Roles of Thyroxine Binding Proteins \"\"; \"\"6. Conclusion \"\"; \"\"References \"\"; \"\"Markers of Thyroid Function \"\"; \"\"Abstract\"\"; \"\"I. Introduction \"\"; \"\"II. Current Methods for the Evaluation  of Thyroid Function \"\"; \"\"2. Subclinical Thyroid Dysfunction \"\"; \"\"3. Clinical Diagnosis Indexes \"\""]
[{"$nulls":4},"\"\" III. Evaluation of Thyroid Hormone Tissue Activity \"\"\"\"IV. Conclusions \"\"; \"\"Acknowledgments \"\"; \"\"References\"\"; \"\"Redox Signaling in Thyroid Hormone Action: A Novel Strategy for Liver Preconditioning \"\"; \"\"Abstract \"\"; \"\"Abbreviations \"\"; \"\"Introduction \"\"; \"\"Genomic and Non-Genomic Mechanisms in Thyroid Hormone Calorigenesis \"\"; \"\"Relationship Between Thyroid Hormone Calorigenesis And Hepatic ROS Generation \"\"; \"\"Kupffer-Cell Activation and Up-Regulation of Cytokine Expression in Hyperthyroid State \"\""]
[{"$nulls":4},"\"\"T3-Induced Kupffer-Cell-Dependent Up-Regulation of Hepatocyte Antioxidant and Anti-Apoptotic Protein Expression \"\"\"\"T3-Induced Kupffer-Cell-Dependent Up-Regulation of Hepatocyte Acute-Phase Response \"\"; \"\"T3-Induced Kupffer Cell-Dependent Up-Regulation of Hepatocyte Proliferation \"\"; \"\"Liver Preconditioning by Thyroid Hormone\"\"; \"\"Acknowledgments \"\"; \"\"References\"\"; \"\"Different Effect of Thyroxine on Behavior and the Brain Serotonin Receptors of Catalepsy-Prone and Catalepsy-Resistant Mouse Strains \"\"; \"\"Abstract\"\"; \"\"Introduction \"\"; \"\"Experimental Procedures \"\"; \"\"Results \"\""]
[{"$nulls":4},"\"\"Discussion \"\"\"\"Acknowledgments \"\"; \"\"References \"\"; \"\"Involvement of Thyroid Hormones in the Regulation of Mitochondrial Oxidations in Mammals and Birds \"\"; \"\"Abstract \"\"; \"\"Introduction \"\"; \"\"The Stimulation of Mitochondrial Activity by Short-Term Mechanisms \"\"; \"\"The Mitochondrial Target of Thyroid Hormones: Long-Term Pathways \"\"; \"\"Conclusion \"\"; \"\"Aknowledgments \"\"; \"\"References \"\"; \"\"Immuno-Pathogenesis of Thyroid Associated Ophthalmopathy (TAO). The Effect of Novel Treatment of TAO with Anti-TNFÎ± and Anti-CD 20 Monoclonal Antibodies \"\"; \"\"Abstract \"\"; \"\"I. Introduction \"\""]
[{"$nulls":4},"\"\"II. Immunopathogenesis of Gravesâ€? Orbitopathy\"\"\"\"III. New Immunomodulators in the Treatment of Gravesâ€? Ophthalmopathy\"\"; \"\"IV. Conclusions \"\"; \"\"References \"\"; \"\"Managing Moderate to Severe Graves Ophthalmopathy: An Up-to-Date Review \"\"; \"\"Abstract \"\"; \"\"Corticosteroids \"\"; \"\"Alternative Immunomodulatory Therapy \"\"; \"\"Results \"\"; \"\"Clinical Measurement of Disease Severity and Treatment Response \"\"; \"\"Summary of Outcomes \"\"; \"\"Conclusion \"\"; \"\"References\"\"; \"\"Thyroid Function in Infants of Mothers with Gravesâ€? Disease and Hyperthyroidism During Pregnancy \"\"; \"\"Abstract \"\""]
[{"$nulls":4},"\"\"Introduction \"\""]